rs74644143

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1

The NM_002187.3(IL12B):​c.749G>A​(p.Arg250Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000335 in 1,613,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 0 hom. )

Consequence

IL12B
NM_002187.3 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.0940
Variant links:
Genes affected
IL12B (HGNC:5970): (interleukin 12B) This gene encodes a subunit of interleukin 12, a cytokine that acts on T and natural killer cells, and has a broad array of biological activities. Interleukin 12 is a disulfide-linked heterodimer composed of the 40 kD cytokine receptor like subunit encoded by this gene, and a 35 kD subunit encoded by IL12A. This cytokine is expressed by activated macrophages that serve as an essential inducer of Th1 cells development. This cytokine has been found to be important for sustaining a sufficient number of memory/effector Th1 cells to mediate long-term protection to an intracellular pathogen. Overexpression of this gene was observed in the central nervous system of patients with multiple sclerosis (MS), suggesting a role of this cytokine in the pathogenesis of the disease. The promoter polymorphism of this gene has been reported to be associated with the severity of atopic and non-atopic asthma in children. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0034862459).
BP6
Variant 5-159318842-C-T is Benign according to our data. Variant chr5-159318842-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 541815.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00185 (282/152214) while in subpopulation AFR AF= 0.0065 (270/41538). AF 95% confidence interval is 0.00586. There are 0 homozygotes in gnomad4. There are 108 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
IL12BNM_002187.3 linkuse as main transcriptc.749G>A p.Arg250Gln missense_variant 6/8 ENST00000231228.3 NP_002178.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
IL12BENST00000231228.3 linkuse as main transcriptc.749G>A p.Arg250Gln missense_variant 6/81 NM_002187.3 ENSP00000231228 P1
IL12BENST00000696750.1 linkuse as main transcriptc.119G>A p.Arg40Gln missense_variant 3/5 ENSP00000512849
IL12BENST00000696751.1 linkuse as main transcriptc.*244G>A 3_prime_UTR_variant, NMD_transcript_variant 5/7 ENSP00000512850
ENST00000521472.6 linkuse as main transcriptn.290-6692C>T intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.00186
AC:
283
AN:
152096
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00654
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00144
GnomAD3 exomes
AF:
0.000461
AC:
116
AN:
251406
Hom.:
0
AF XY:
0.000324
AC XY:
44
AN XY:
135882
show subpopulations
Gnomad AFR exome
AF:
0.00664
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000177
AC:
258
AN:
1461744
Hom.:
0
Cov.:
32
AF XY:
0.000140
AC XY:
102
AN XY:
727190
show subpopulations
Gnomad4 AFR exome
AF:
0.00660
Gnomad4 AMR exome
AF:
0.000134
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000144
Gnomad4 OTH exome
AF:
0.000199
GnomAD4 genome
AF:
0.00185
AC:
282
AN:
152214
Hom.:
0
Cov.:
32
AF XY:
0.00145
AC XY:
108
AN XY:
74418
show subpopulations
Gnomad4 AFR
AF:
0.00650
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.000314
Hom.:
0
Bravo
AF:
0.00198
ESP6500AA
AF:
0.00522
AC:
23
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000585
AC:
71
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 22, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingCenter for Genomics, Ann and Robert H. Lurie Children's Hospital of ChicagoMar 30, 2021IL12B NM_002187.2 exon 6 p.Arg250Gln (c.749G>A): This variant has not been reported in the literature and is present in 0.6% (167/24966) of African alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/5-158745850-C-T). This variant is present in ClinVar (Variation ID:541815). This variant amino acid Glutamine (Gln) is present in several species including multiple mammals, and it is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
13
DANN
Benign
0.90
DEOGEN2
Benign
0.097
T
Eigen
Benign
-0.93
Eigen_PC
Benign
-0.92
FATHMM_MKL
Benign
0.013
N
LIST_S2
Benign
0.73
T
M_CAP
Benign
0.0054
T
MetaRNN
Benign
0.0035
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
L
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.20
T
PROVEAN
Benign
0.080
N
REVEL
Benign
0.073
Sift
Benign
0.23
T
Sift4G
Benign
0.30
T
Polyphen
0.0080
B
Vest4
0.11
MVP
0.51
MPC
0.34
ClinPred
0.012
T
GERP RS
0.39
Varity_R
0.33
gMVP
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs74644143; hg19: chr5-158745850; COSMIC: COSV51454715; COSMIC: COSV51454715; API